RECIDIVE LIMITED
Company number 14615517 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
RECIDIVE LIMITED - Analysis Report
Company Number: 14615517
Analysis Date: 2025-07-29 19:02 UTC
Financial Health Assessment for RECIDIVE LIMITED
1. Financial Health Score: Grade B
Explanation:
RECIDIVE LIMITED is a very young, micro-entity company with minimal financial activity to date. It holds a healthy "dormant" status with positive net current assets, minimal liabilities, and a positive equity balance. The absence of debts and the presence of some working capital indicate no immediate financial distress. However, the extremely limited financial data and operational history limit a more confident higher grading.
2. Key Vital Signs
| Metric | Value | Interpretation |
|---|---|---|
| Company Status | Active | The business is currently registered and operational. |
| Account Category | Dormant | Indicates no significant trading or financial activity during the year; minimal transactions. |
| Net Current Assets | £10 | Positive working capital, albeit very small, suggests liquidity is adequate for current needs. |
| Net Assets (Shareholders’ Funds) | £10 | Positive equity capital; no accumulated losses or liabilities eroding shareholder funds. |
| Fixed Assets | £0 | No long-term assets acquired yet, typical for a startup or dormant company. |
| Employees | 1 (Director) | Sole operator/director, consistent with micro-entity status and early stage of business. |
| Filing Compliance | Up to Date | No overdue accounts or confirmation statements, indicating good regulatory compliance. |
3. Diagnosis
RECIDIVE LIMITED currently exhibits the "vital signs" of a nascent or dormant company. The financial "symptoms"—zero fixed assets, nominal current assets of £10, no liabilities, and a single director—indicate the company has not yet begun active trading or significant business operations.
The balance sheet is extremely lean, consistent with a company that has not started generating revenues or incurring expenses. The positive net current assets and shareholders’ funds reflect the initial capital investment or nominal share capital issued at incorporation.
The "healthy cash flow" here is more theoretical, as there is minimal cash or liquid assets recorded, but the absence of liabilities shows no immediate financial distress or solvency issues.
Overall, the business is in a stable but embryonic phase. Without trading history, profitability, or operational scale, the financial health is cautiously positive but limited in scope.
4. Recommendations
- Commence Trading and Revenue Generation: To move beyond dormancy, the company should focus on starting business operations aligned with its retail via internet model (SIC 47910). This will generate financial data to better assess ongoing health.
- Maintain Strong Cash Flow Management: As trading begins, ensure cash inflows (sales receipts) consistently exceed outflows (costs, expenses) to build liquidity buffer and avoid symptoms of financial distress.
- Build Financial Records and Controls: Keep accurate and timely accounting records to facilitate future financial analysis and compliance with filing deadlines. This will support better diagnostic assessments in future years.
- Monitor Working Capital Needs: As the company grows, carefully manage current assets and liabilities to maintain positive net current assets, which indicate operational liquidity health.
- Plan for Asset Acquisition: Consider investing in fixed assets or inventory as business scales to support operations, while monitoring return on investments.
- Compliance and Governance: Continue to meet Companies House filing deadlines to avoid penalties and demonstrate sound governance.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.